Species-Specific Epitope
|
|
- Leslie Curtis
- 6 years ago
- Views:
Transcription
1 INFECTION AND IMMUNITY, Jan. 1992, p /92/1143-7$2./ Copyright 1992, American Society for Microbiology Vol. 6, No. 1 A 34- to 38-Kilodalton Cryptococcus neoformans Glycoprotein Produced as an Exoantigen Bearing a Glycosylated Species-Specific Epitope A. J. HAMILTON,'* L. JEAVONS,1 P. HOBBY,2 AND R. J. HAY Dermatology Unit' and Renal Unit,2 Clinical Sciences Department, 18th Floor, Guy's Tower, Guy's Hospital, London Bridge, London SE] 9RT, United Kingdom Received 15 August 1991/Accepted 17 October 1991 Three monoclonal antibodies (MAbs), all of the immunoglobulin Gl subclass, were raised against Cryptococcus neoformans by using the technique of cyclophosphamide ablation of B-cell responses against shared epitopes of the cross-reactive fungus Trichosporon beigelii. MAb 3C2 was reactive against the encapsulated and nonencapsulated isolates of C. neoformans var. neoformans by enzyme-linked immunosorbent assay (ELISA) and Western blot (immunoblot), and in addition to a 34- to 38-kDa deterniinant, it recognized a series of lower-molecular-weight species. 3C2 also reacted strongly with culture supernatant preparations of C. neoformans var. neoformans by ELISA. 3C2 showed no recognition of either T. beigelii or C. neoformans var. gayii antigens. Enzymatic deglycosylation followed by reaction with 3C2 on Western blots revealed that sialic acid was an integral part of the determinant, together with N-acetylglucosaminylasparagine and a-mannose. Proteolytic digestion showed that the epitope was pepsin sensitive and that it also contained tryptophan and glycine and/or leucine as determinants of recognition by 3C2. The pl of the glycoprotein was 7.1. Affinity chromatography-purified antigen did not exhibit proteolytic activity on sodium dodecyl sulfate-polyacrylamide substrate gels. Indirect fluorescence antibody tests revealed that 3C2 labelling was confined to the cell membrane and cytoplasm of yeasts. The remaining MAbs, 7H4 and 5G5, recognized both capsulated and nonencapsulated strains of C. neoformans var. neoformans by both ELISA and Western Blot, identifying linear determinants with molecular masses of 36 and 3 kda. They were unreactive against culture supernatant antigen (exoantigen) from either variant of C. neoformans. The disease cryptococcosis is caused by either of the two varieties of the encapsulated yeast Cryptococcus neoformans, C. neoformans var. neoformans and C. neoformans var. gattii, and is characterized by dissemination from a pulmonary focus and a potentially fatal form of meningitis. Though the disease may occur in individuals who show no evidence of immunosuppression, it has recently attracted much interest because of its prevalence in patients infected with human immunodeficiency virus. For instance, a recent study in Zaire has shown, by screening for circulating cryptococcal antigen, that up to 11% of human immunodeficiency virus-positive individuals had been infected with the organism (2). At present, the diagnosis of the disease relies on either isolation of the organism or the detection of capsular polysaccharide antigen by using the latex agglutination test with either serum or cerebrospinal fluid (11, 16). Though the latex agglutination test has proved very useful for diagnosis, it is limited to some extent by the crossreactivity of the antigen with other fungal pathogens, such as Trichosporon beigelii (4, 6), and by the fact that some human immunodeficiency virus-positive individuals still show positive tests long after other signs of disease have disappeared. It is not clear whether this reflects failure to eliminate capsular polysaccharide or persistence of infection (5). Therefore, it would be useful to identify other speciesspecific exoantigens produced by C. neoformans, the occurrence and levels of which in serum or cerebrospinal fluid might more accurately reflect the number of viable yeast cells present. Recently, our laboratory has produced spe- * Corresponding author. 143 cies-specific monoclonal antibodies (MAbs) against a range of fungal pathogens by using the technique of cyclophosphamide ablation of shared B-cell responses (1, 12), and most recently, we have demonstrated the presence of a 11- to 12-kDa molecule in the culture filtrate of C. neoformans which bears a species-specific epitope (13). In this paper, we report the occurrence and preliminary biochemical characterization of a smaller glycoprotein (34 to 38 kda) produced as an exoantigen which bears a species-specific epitope and as such has potential for use in serodiagnosis. MATERIALS AND METHODS Antigen preparation. Lyophilized isolates of C. neoformans var. gattii (2), Cryptococcus laurentii (1), Cryptococcus albidus (1), Aspergillusfumigatus (2), Aspergillusflavus (2), Candida albicans (1) and Candida tropicalis (1) were obtained from the National Collection of Pathogenic Fungi (NCPF), Mycological Reference Laboratory, Colindale, London, United Kingdom (NCPF 3169 and NCPF 317, NCPF 3141, NCPF 314, NCPF 21 and NCPF 2978, NCPF 228 and NCPF 2617, NCPF 3343, and NCPF 3114, respectively). The isolates were reconstituted with.5 ml of sterile water, inoculated onto Sabouraud agar, and then expanded into larger (25 ml and 3 liters) volumes of Sabouraud liquid culture medium. Two additional strains of C. neoformans (B351, encapsulated, and B4131, nonencapsulated) were obtained from June Kwon-Chung, Mycology Department, National Institutes of Health, Bethesda, Md., while four isolates of C. neoformans var. neoformans (NCPF 3171, serotype D; 3168, serotype A; 349 and 381, serotypes unknown), together with two isolates of T. beigelii
2 144 HAMILTON ET AL. (NCPF 4874 and 5246), were obtained from the Mycology Laboratory, St. John's Hospital for Diseases of the Skin, London, United Kingdom, and treated as described above. Mycelial isolates of Histoplasma capsulatum var. capsulatum (two isolates), Blastomyces dermatitidis (one), Paracoccidioides brasiliensis (three), and Sporothrix schenckii (two) (NCPF 41 and NCPF 488; NCPF 476; NCPF 3285, NCPF 4115, and NCPF 495; and NCPF 3181 and NCPF 3286, respectively) were also obtained from the National Collection of Pathogenic Fungi, transformed to the yeast phase at 37 C on slopes of brain heart infusion medium to which.2 mm L-cysteine was added, and subsequently subcultured in brain heart infusion broth at 37 C. All fungal preparations were collected by filtration (Whatman no. 2 filter paper), washed in phosphate-buffered saline (PBS;.1 M, ph 7.4), and divided into two subsamples, to one of which a cocktail of protease inhibitors was added (1, 2) for subsequent use as antigen for Western blotting (immunoblotting). Each sample was then homogenized on ice by using glass ball ballotini in a bead beater (Biospec Products, Bartlesville, Oklahoma) by using 2 1-min pulses separated by 5-min gaps, which had previously been shown by protein estimation and Western blotting to yield the largest amounts of undenatured protein. The soluble cell extracts were collected and centrifuged at 2, x g for 7 min, and the supernatants were retained to yield cytoplasmic antigens, which were divided into portions and stored at -7 C. For the various Cryptococcus strains, the culture filtrates were retained, dialyzed against polyethylene glycol 8 to 1/1 of their original volumes, and then redialyzed overnight against PBS at 4 C to yield a crude exoantigen preparation. Protein concentration was estimated in each sample by using the Coomassie blue method (17). Immunization protocol. The immunization schedule incorporating cyclophosphamide was as previously described (13) with T. beigelii (NCPF 4874) and C. neoformans var. neoformans (B4131) as antigens, except that the test bleed and differential enzyme-linked immunosorbent assay (ELISA) took place on day 26. Fusion protocol. Cells of the myeloma line Sp2/ were fused with spleen cells from the chosen mouse at a ratio of 1:1 by using polyethylene glycol 4 according to a modification of an existing protocol (24), and the resulting hybridomas were plated onto 96-well microtiter plates. At 7 days postfusion, colonies were screened by ELISA with the immunizing antigens and the encapsulated C. neoformans isolate B351 (13). Clones from wells differentiating between the three antigens were subcloned twice by limiting dilution before expansion into 25-ml flasks. Female BALB/c mice previously primed with pristane were given intraperitoneal injections of 14 hybridoma cells, and ascitic fluid was collected 14 to 21 days later. MAbs were purified from ascitic fluids using a protein A-Sepharose column (Pharmacia) (9). All three of the MAbs described in this study were effectively eluted by a.1 M citric acid buffer solution (ph 6), and MAb subclassing was then performed (13). Protein estimations of the eluted immunoglobulins were carried out as previously described (17). Purified MAbs (initial concentration, 1,ug ml-') in PBS- Tween were then assessed for reactivity by ELISA (1,ul per well) for all the cytoplasmic fungal antigens described above. All antigens were used at protein concentrations of 1,ug per well. In addition, MAbs were assessed for recognition of culture supernatant of C. neoformans by ELISA; the procedure was done as described previously (13) except that the antigen was diluted progressively by a ratio of 1:1, INFECT. IMMUN. starting with an initial concentration of 1,ug per well, in order to determine the lowest detectable concentration of antigen. In all the ELISAs, either Histoplasma capsulatumspecific MAb C69 (12) or PBS-Tween was used as the negative control. Polyacrylamide gel electrophoresis (PAGE), electroblotting, and immunoenzyme development. Each of the C. neoformans var. neoformans, C. neoformans var. gattii, and T. beigelii antigens and one of each of the other antigens containing protease inhibitors (total of 1,ug of protein per gel) were electrophoresed on a sodium dodecyl sulfate (SDS)-7.5% (wt/vol) polyacrylamide gel at 2 V for 1 h. After semidry blotting, immunoenzyme development was performed with MAbs at a protein concentration of 25,ug per strip (12, 13). Affinity chromatography. One gram of CNBr-activated Sepharose 4B (Pharmacia) was swollen in 2 ml of ice-cold 1 mm HCl by washing on a sintered glass funnel for 15 min. Protein A-purified MAb 3C2 (15 mg) in coupling buffer (.1 M NaHCO3,.5 M NaCl [ph 8.5]) was added to the Sepharose, and the two were mixed by end-over-end rotation for 6 h at room temperature. After centrifugation (5 x g for 5 min), the supernatant was removed and active groups were blocked overnight at 4 C by the addition of 2 M ethanolamine (ph 8.). The Sepharose was then poured into a 5-ml syringe blocked with glass wool and washed alternately with washing buffer at ph 4. (.1 M glacial acetic acid,.5 M NaCl) and washing buffer at ph 8. (.1 M Tris base,.5 M NaCl). Five micrograms of C. neoformans (capsular negative) cytoplasmic antigen was then added to the column in 2 ml of coupling buffer and recirculated overnight at 4 C in a closed system running at.5 ml/min. A28 was monitored as a baseline was established by flushing with coupling buffer. Bound antigen was then eluted by progressive washes with.2 M glycine HCI (ph 4., 3., and 2.2) in volumes of 25 ml each and immediately neutralized prior to analysis by ELISA, SDS-PAGE, and protein estimation. Substrate SDS-polyacrylamide gels. SDS-7.5% polyacrylamide gels were copolymerized with either.1% bacterio- (GIBCO) or 2% casein (BDH). Ten micro- logical gelatin grams of affinity chromatography-purified 34- to 38-kDa antigen (unreduced and unboiled) was loaded into each of four wells together with a commercial preparation of pepsin (Sigma; 2 U total in.1 M citrate buffer, ph 2.) and molecular weight markers (GIBCO). Gels were then electrophoresed quickly (25 ma per gel) at 4 C, placed in Triton X-1, and rocked at room temperature for 3 min to remove residual SDS. The gel was then further incubated in PBS for 6 min, the buffer was replaced, and the gel was placed overnight at 37 C prior to Coomassie brilliant blue staining and destaining. Isoelectric focusing. Samples of (1,ug) of cytoplasmic yeast (C. neoformans, capsular negative) were run in a 7.5% polyacrylamide gel containing 2% ampholytes (Pharmacia) in the pl range of 3 to 1 on a multiphor electrophoresis system (Pharmacia) with a thermostatic plate cooled to 1 C. The ph gradient of the gel was measured by using Electran colored protein markers (BDH). The gel was capillary blotted onto an immobilin membrane, and immunoenzyme development was performed by using 3C2. Enzymatic deglycosylation of the 34- to 38-kDa antigen. Subsamples (1,ug) of C. neoformans (capsular-negative) cytoplasmic yeast antigen were incubated for 24 h with the following enzymes: a-mannosidase (Sigma) in.1 M sodium citrate buffer (ph 4.) at 25 C,,-mannosidase (Sigma) in.1
3 VOL. 6, 1992 M sodium citrate buffer (ph 4.) at 25 C, neuraminidase (BDH) in.1 M potassium acetate buffer (ph 4.5) supplemented with 2 mm CaCl at 37 C, a-galactosidase (Sigma) in.1 M sodium citrate (ph 4.) at room temperature,,-galactosidase (Sigma) in.4 M sodium citrate (ph 4.) at room temperature, a-glucosidase (Sigma) in.1 M sodium acetate supplemented with.5% EDTA (ph 6.) at 37 C, and peptide N-glycanase F in 25,ul of digestion buffer consisting of 3,ul of 1 mm 1,1-phenanthroline, 5,ul of 7.5% NP-4, and 9,u1 of 55 mm sodium phosphate (ph 8.6) at 37 C. With peptide N-glycanase F, some of the antigen was reduced prior to digestion in 1% SDS and 1.6% 2-mercaptoethanol (boiled for 3 min). All enzymes were used in volumes equivalent to 1 U of activity. After digestion, all samples were boiled for 3 min in the presence of 1% SDS and 1.6% 2-mercaptoethanol, loaded onto SDS-7.5% polyacrylamide gels along with molecular weight markers, and electrophoresed at 2 V. Gels were then subsequently blotted onto Immobilin prior to immunoenzyme development with MAb 3C2. Protease digestion of the 34- to 38-kDa antigen. Subsamples (1,ug) of C. neoformans cytoplasmic antigen were treated with each of the following enzymes for 24 h (except where stated) under the following conditions: pepsin (Sigma) in 1 mm HCI at 37 C; protease V8 (Sigma) in.1 M PBS (ph 7.2) at 37 C; trypsin (Sigma), N-tosylamide-L-phenylamine chloromethyl ketone (TPCK) treated, in.67 M sodium phosphate buffer (ph 7.6) at room temperature; a-chymotrypsin (Sigma) in a solution of 8,u1 of 2 M CaCl and 3 ml of Tris-HCl buffer (ph 7.6) at room temperature; and papain (Sigma) in a solution of 1 ml of 3 M NaCl in 1 ml of a mixture of 2 mm EDTA and 5 mm L-cysteine (ph 6.2) at room temperature. All enzymes were used at concentrations equivalent to 5 U. Samples (1,ug) were also subjected to the following chemical treatments: hydroxylamine (Sigma), 5 mm in distilled water, at room temperature; 2-(2'-nitrophenylsulfonyl)-3-methyl-3'-bromoindolenine (BNPS-skatole) (Pierce), 1 mg ml-' in 7% distilled acetic acid with.1% phenol for 48 h at room temperature and with a 1-fold excess of the reagent, followed by the addition of a 1-fold excess of 2-mercaptoethanol, a further incubation for 5 h at 37 C, and extraction of excess BNPS-skatole with ethyl acetate (14); pretreatment with BNPS-skatole followed by exposure of the antigen to a 12-fold excess of N-bromosuccinimide (Sigma), 1 mg ml-' in aqueous 5% distilled acetic acid for 2 h at 3 C; and cyanogen bromide (Sigma),.5 g in 1 ml of.1 M HCl for 48 h at room temperature. Samples were treated and analyzed by SDS-PAGE and Western blotting in the same way as those prepared for the deglycosylation study above. Immunofluorescent location of antigen. Immunofluorescent location of antigen was performed as previously described (13) with C. neoformans (B351) as test organism and MAbs diluted 1:1 in PBS-Tween. RESULTS The ELISA performed with the polyclonal serum samples from the four mice used for the immunization protocol identified one mouse with significantly higher titers to the C. neoformans (encapsulated) strain antigen than those to either the nonencapsulated C. neoformans or T. beigelii antigens used in the immunization protocol, and this animal was used for the fusion study. The other animals showed a limited differential response to the various antigens. Control mice, which underwent the same immunization protocol but CRYPTOCOCCUS NEOFORMANS EXOANTIGEN $ 4 ah. 4O' 2 A a v 7H4 a 5G5 3C2 MAbs FIG. 1. Reactivities of three MAbs against a range of antigens, as defined by absorbance values in ELISA., C. neoformans nonencapsulated B4131; *, B351; A, NCPF 3171; V, NCPF 381; *, NCPF 3168; *, NCPF 349; O, NCPF 3169; O, NCPF 317; A, T. beigelii NCPF 4874 (NCPF 3169 and NCPF 317 are C. neoformans var. gattii; the others are C. neoformans encapsulated isolates, except B4131). Isolates of all other fungi tested gave values below.1 (data not shown). without the use of cyclophosphamide, showed no difference in serum reactivities in a similar ELISA (data not shown). Three hybridomas were chosen after a total of 1,5 were screened by ELISA. After successive subclonings, three MAbs, designated 3C2, 7H4, and 5G5, were obtained, and all three were shown to belong to the immunoglobulin Gl subclass. By ELISA, MAbs 3C2 and 7H4 recognized the nonencapsulated and capsular isolates of C. neoformans but showed no reactivity to T. beigelii, while MAb SG5 recognized all of these antigens (Fig. 1). None of the MAbs showed any reactivity to C. neoformans var. gattii or to any of the other fungal antigens tested. 3C2 was strongly reactive to culture supernatant antigen from C. neoformans var. neoformans isolates and was able to detect antigen at a protein concentration as low as.1 ng (Fig. 2). In contrast, 7H4 and 5G5 failed to recognize exoantigen. Western blot analysis demonstrated that 3C2 recognized a determinant at 34 to 38 kda on reduced gels, two major bands at approximately 26 to 28 and 2 to 22 kda, and four minor bands on blots of nonencapsulated. and encapsulated isolates of C. neoformans (Fig. 3) but showed no reaction to any other antigens except culture supernatant antigen from C. neoformans var. neoformans (data not shown). The pattern of recognition on nonreduced blots was exactly the same. MAbs 7H4 and 5G5 recognized two bands at 36 kda and approximately 3 kda and showed the same pattern of antigen recognition as that shown by ELISA. Isoelectric focusing of nonencapsulated C. neoformans cytoplasmic antigen followed by blotting and immunoenzyme development with 3C2 revealed a single strong band with a pl of 7.1, whereas over 8% of the remaining cytoplasmic antigens appeared to have pis of 5. and less. a A U V A S
4 ! 146 HAMILTON ET AL. INFECT. IMMUN ) wc 4 a~~~~~~~~~ lo-11 e12 13 Antigen concentration (9) FIG. 2. Reactivities of three MAbs to culture supernatant antigens by ELISA., 3C2; O, 5G5; A, 7H4. Other C. neoformans encapsulated-isolate antigens gave a pattern similar to that shown here for B351. A total of 35,ug of 3C2 antigen was eluted from affinity there was no evidence of proteolytic clearing compared with chromatography columns (two columns loaded with a total that of the positive controls. of 15 mg each of cytoplasmic antigen) with glycine-hcl Figure 4 indicates the effect of deglycosylation on the buffer (ph 2.2). The fractions eluted with glycine-hcl at ph recognition of the 34- to 38-kDa- glycoprotein and lowermolecular-weight species by 3C2 when visualized by West- 4 and ph 3 were negative when reacted with MAb 3C2 by ELISA and contained undetectable amounts of protein. ern blot. Neuraminidase completely destroys recognition as SDS-polyacrylamide gels stained with Coomassie brilliant does peptide N-glycanase F. There is also a partial decrease blue revealed the predominance of the 34- to 38-kDa antigen in reactivity with treatment with a-mannosidase.,b-mannosidase, a-glycosidase, P-glycosidase, a-galactosidase, and in the eluent. However, when these samples were run on SDS-polyacrylamide substrate gels (with gelatin and casein), 3-galactosidase had no obvious effect on either intensity or the molecular weight of species recognized by 3C2. Figure 5 shows the effect of proteolysis on epitope recognition by A B C D E F G H I 34-38kD> c36kd,c3okd 26-28kD> _ 2-22kD> ' 'I awi 34-38kD> WI FIG. 3. Western blot reactivities of three MAbs. Lanes A, B, FIG. 4. Effect of various deglycosylation enzymes on the reactivity of 3C2 as determined by Western blot. Lanes: A, untreated and C, reactivity of 3C2 with antigens B351 and B4131 (C. neoformans) and NCPF 4874 (T. beigelio), respectively; lanes D, E, control; B, a-mannosidase; C, 1-mannosidase; D, neuraminidase; and F, reactivity of 7H4 with same antigens; lanes G, H, and I, E, a-galactosidase; F,,B-galactosidase; G, peptide N-glycanase F; reactivity of 5G5 with same antigens. H, a-glucosidase; I,,B-glucosidase.
5 VOL. 6, 1992 CRYPTOCOCCUS NEOFORMANS EXOANTIGEN kD>Pw 2-22kD> A BC D E FG H I J FIG. 5. Effect of various proteolytic enzymes on reactivity of 3C2 as determined by Western blot. Lanes: A, control; B, papain; C, pepsin; D, trypsin; E, hydroxylamine; F, V8 protease; G, a-chymotrypsin; H, CNBr; I, BNPS-skatole; J, BNPS-skatole followed by N-bromosuccinimide. 3C2. Of the enzymes used, papain, pepsin, and a-chymotrypsin prevented recognition by 3C2, whereas V8 protease and trypsin digestion did not. With the latter, low-molecularweight species were recognized, indicating digestion of the 34- to 38-kDa molecule and its smaller components but not of the epitope itself. Of the chemical treatments used, hydroxylamine and cyanogen bromide did not destroy the epitope, whereas BNPS-skatole did; it was not possible to deduce the effect of N-bromosuccinimide following treatment with BNPS-skatole. Immunofluorescence studies demonstrated strong staining of cell membrane and cytoplasm by all the MAbs with the four Cryptococcus isolates tested (Fig. 6), with no recognition of either the cell wall or capsule. DISCUSSION Until now, the MAbs raised against C. neoformans have been directed against capsular polysaccharide (7, 8, 19) since this material has been identified as the major exoantigen produced by this pathogen. Murphy et al. (15) defined three components within the culture filtrate from C. neoformans: high-molecular-weight glucuronoxylomannan, galactoxylomannan, which has been extensively characterized (18, 21) and against which MAbs have been raised (22), and a mannoprotein. None of the MAbs raised have been used to supplement the latex agglutination test, and while the test has proven to be generally effective, its detection of circulating antigen in patients suffering from AIDS, even after infection has apparently ceased, has made the isolation of other exoantigens, whose presence may more accurately reflect active infection in such situations, of some importance. In this regard, it is clear from our data that we have succeeded in raising a second MAb (3C2), in addition to the MAbs already detailed (13), that not only is capable of detecting an exoantigen of C. neoformans at extremely low concentrations by conventional ELISA but also is directed against some noncapsular component. It is clearly not related to either glucuronoxylomannan or galactoxylomannan, and any similarity to previously identified mannoprotein can be dismissed since mannoprotein has been shown to be a Downloaded from on May 2, 218 by guest FIG. 6. Immunofluorescence reactivity of 3C2 against cryostat sections of C. neoformans. Bar represents 15,um.
6 148 HAMILTON ET AL. nonstructural element of the cell wall by immunoelectron microscopy (23), whereas 3C2 is reactive by immunofluorescence to the cytoplasm but not the cell wall or capsule of C. neoformans. Any relationship between the 34- to 38-kDa glycoprotein recognized by 3C2 and the 11- to 12-kDa molecule identified by our previously defined MAb 7C9 (13) is unclear, although there appears to be some overlap in molecular weight recognition since 7C9 is also reactive to a series of lower-molecular-weight species, including one at 36 to 38 kda. Our unpublished data suggest that 7C9 recognizes a nonglycosylated epitope on a glycoprotein, though our studies of this are at a preliminary stage. Some aspects of the composition of the epitope which is recognized by 3C2 can be deduced from the effects of various deglycosylation and proteolytic enzymes. Neuraminidase specifically removes terminal sialic acids, the result being the abolition of recognition by 3C2, indicating the primacy of this carbohydrate in the composition of the epitope. The effect of peptide N-glycanase F demonstrates the presence of N-acetylglucosaminyl asparagine residue(s) to which the sialic acid(s) will be linked, either directly or via an oligosaccharide chain, though it may be that the importance of the acetylglucosaminyl residue is only as a linkage group to which the major determinant, sialic acid, is joined. There is also evidence for the existence of a-mannose in the epitope, though its presence does not appear to be an absolute determinant for the recognition by 3C2. a-mannose probably exists as side chains extending from the N-acetylglucosaminyl group; only in this sort of format would they be accessible to the exoglycosidic action of ot-mannosidase, which leads to the reduction in recognition by 3C2. It is conceivable that abolition of recognition by 3C2 after deglycosylation is a result of conformational change; however, conformationally defining carbohydrates are likely to be internal and so would not be accessible to the various enzymes employed in this study. When the specificities of the enzymatic and chemical cleavage of the peptide backbone are interpreted, it becomes immediately clear that tryptophan is an integral part of the epitope, since BNPS-skatole and a-chymotrypsin destroy the reactivity of 3C2. The latter agent also cleaves at tyrosine and phenylalanine as well as tryptophan, so the existence of one or both of these residues cannot be ruled out. Similarly, whereas the broadly active enzyme papain cuts at any one of lysine, arginine, leucine, and glycine and clearly destroys the epitope, the fact that trypsin, which cuts at arginine and lysine, does not prevent recognition by 3C2 suggests that leucine or glycine or both are important residues within the epitope. Unfortunately, little can be deduced from the loss of 3C2 reactivity by using N-bromosuccinimide since, in addition to cleaving at tyrosine and histidine, it is also active at tryptophan. Finally, the absence of any effect by CNBr and V8 protease indicates the absence of methionine, aspartic acid, and glutamic acid in the epitope, though the fact that the molecular weight of the species recognized by 3C2 declines after treatment suggests the presence of such residues elsewhere in the molecule. While 7H4 and 5G5 recognized only two bands by Western blot at 36 and 3 kda, 3C2 was reactive to a large number of epitopes with molecular masses below 34 kda. This may suggest that 3C2 recognizes an epitope shared by a range of low-molecular-weight antigens, but we think it more likely that 3C2 is reacting with breakdown products of the 34- to 38-kDa molecule, despite the fact that protease inhibitors were added to the antigen used in Western blotting. Preliminary attempts to directly detect circulating antigen INFECT. IMMUN. in patients' sera and cerebrospinal fluid by both ELISA and Western blot have proved only partially successful, and so we are presently attempting to isolate the antigen to which 3C2 binds in large quantities via a combination of ionexchange (using the pl data disclosed) and affinity chromatography, with a view to raising an immunoglobulin M MAb against it. When combined with 3C2, the latter would form the basis for a specific-antigen-trap ELISA similar to that developed for other pathogens (3). Such a test would have to be both highly sensitive and reproducible, though it would immediately have the advantage of enabling infections by the two varieties of C. neoformans to be distinguished since 3C2 is only reactive to C. neoformans var. neoformans. It is also hoped that highly purified antigen can be subjected to peptide sequencing in an attempt to define a function for the molecule since it appears not to perform the most obvious role of fungal exoantigens, that of proteolytic enzyme. The partial information on the amino acid composition of the determinant recognized by 3C2, when combined with peptide sequence data, will allow us to deduce the location of this species-specific epitope and so determine its full amino acid sequence. ACKNOWLEDGMENTS We thank Colin Campbell of the medical Mycology Reference Laboratory, PHLS Laboratory, Colindale, London, and K. J. Kwon-Chung, National Institutes of Health, Bethesda, Md., for supplying us with various fungal isolates. We also thank Mary Moore of the Mycology Department, St. John's Hospital, St. Thomas Hospital, London, for also supplying isolates. This research was funded by a grant from the Wellcome Trust. REFERENCES 1. Bergmeyer, H. U Methods in enzymatic analysis. V. Enzymes 3: peptidases, proteinases and their inhibitors, 3rd ed., p Academic Press, New York. 2. Birk, Y Protease inhibitors. Methods Enzymol. 45: Burkot, T. R., F. Zavala, R. W. Gwadz, F. H. Collins, R. S. Nussensweig, and D. R. Roberts Identification of malaria infected mosquitoes by a two-site enzyme-linked immunosorbent assay. Am. J. Trop. Med. Hyg. 33: Campbell, C. K., A. L. Payne, A. J. Teall, A. Brownell, and D. W. R. Mackenzie Cryptococcal latex antigen test positive in a patient with Trichosporon beigelii infection. Lancet ii: Dismukes, W. E Cryptococcal meningitis in patients with AIDS. J. Infect. Dis. 157: Dolan, C. T Specificity of the latex-cryptococcal antigen test. Am. J. Clin. Pathol. 58: Dromer, F., J. Salamero, A. Contrepois, C. Carbon, and P. Yeni Production, characterization, and antibody specificity of a mouse monoclonal antibody reactive with Cryptococcus neoformans capsular polysaccharide. Infect. Immun. 55: Eckert, T. F., and T. R. Kozel Production and characterization of monoclonal antibodies specific for Cryptococcus neoformans capsular polysaccharide. Infect. Immun. 55: Ey, P. L., S. J. Prowse, and C. R. Jenkin Isolation of pure IgG1, IgG2a and IgG2b immunoglobulins from mouse serum using protein A-sepharose. Biochemistry 15: Figueroa, J., A. J. Hamilton, M. A. Bartholomew, T. Harada, L. E. Fenelon, and R. J. Hay Preparation of speciesspecific murine monoclonal antibodies against the yeast phase of Paracoccidioides brasiliensis. J. Clin. Microbiol. 28: Goodman, J. S., L. Kaufman, and R. Keonig Diagnosis of cryptococcal meningitis. Value of immunologic detection of cryptococcal antigen. N. Engl. J. Med. 285: Hamilton, A. J., M. A. Bartholomew, J. Figueroa, L. E. Fenelon,
7 VOL. 6, 1992 and R. J. Hay A murine monoclonal antibody exhibiting high species specificity for Histoplasma capsulatum var. capsulatum. J. Gen. Microbiol. 136: Hamilton, A. J., M. A. Bartholomew, J. Figueroa, L. E. Fenelon, and R. J. Hay Production of species-specific murine monoclonal antibodies against Cryptococcus neoformans which recognize a noncapsular exoantigen. J. Clin. Microbiol. 29: Hunziker, P. E., G. J. Hughes, and K. J. Wilson Peptide fragmentation for solid-phase microsequencing. Use of N-bromosuccinimide and BNPS-skatole (3-bromo-3-methyl-2-((2-nitrophenyl)thio)-3H-indole). Biochem. J. 187: Murphy, J. W., R. L. Mosley, R. Cherniak, G. H. Reyes, T. R. Kozel, and E. Reiss Serological, electrophoretic, and biological properties of Cryptococcus neoformans antigens. Infect. Immun. 56: Prevost, E., and R. NeweUl Commercial cryptococcal latex kit: clinical evaluation in a medical center hospital. J. Clin. Microbiol. 8: Read, S. M., and D. H. Northcote Minimization of variation in the responses to different proteins of the Coomassie blue dye-binding assay for proteins. Ann. Biochem. 116: Reiss, E., R. Cherniak, R. Eby, and C. Kaufman Enzyme CRYPTOCOCCUS NEOFORMANS EXOANTIGEN 149 immunoassay detection of IgM to galactoxylomannan of Cryptococcus neoformans. Diagn. Immunol. 2: Spiropulu, C., R. A. Eppard, E. Otteson, and T. R. Kozel Antigenic variation within serotypes of Cryptococcus neoformans detected by monoclonal antibodies specific for the capsular polysaccharide. Infect. Immun. 57: Swinne, D., and C. de Vroey Epidemiologie de la cryptococcuse. Rev. Mycol. 4: Turner, S. H., R. Cherniak, and E. Reiss Fractionation and characterization of galactoxylomannan from Cryptococcus neoformans. Carbohydr. Res. 125: Van de Moer, A., S. L. Salhi, R. Cherniak, B. Pan, M. L. Garrigues, and J. M. Bastide An anti-cryptococcus neoformans monoclonal antibody directed against galactoxylomannan. Res. Immunol. 141: Vartivarian, S. E., G. H. Reyes, E. S. Jacobson, P. G. James, R. Cherniak, and V. R. Muman Localization of mannoprotein in Cryptococcus neoformans. J. Bacteriol. 171: Zola, H., and D. Brooks Techniques for the production and characterization of monoclonal antibodies, p In J. Hurrell (ed.), Monoclonal hybridoma antibodies: techniques and applications. CRC Press, Boca Raton, Fla. Downloaded from on May 2, 218 by guest
Biochemical Comparison of the Cu,Zn Superoxide Dismutases of Cryptococcus neoformans var. neoformans and Cryptococcus neoformans var.
INFECTION AND IMMUNITY, Feb. 1997, p. 488 494 Vol. 65, No. 2 0019-9567/97/$04.00 0 Copyright 1997, American Society for Microbiology Biochemical Comparison of the Cu,Zn Superoxide Dismutases of Cryptococcus
More informationSUPPLEMENTARY MATERIAL
SUPPLEMENTARY MATERIAL Purification and biochemical properties of SDS-stable low molecular weight alkaline serine protease from Citrullus Colocynthis Muhammad Bashir Khan, 1,3 Hidayatullah khan, 2 Muhammad
More informationProtein MultiColor Stable, Low Range
Product Name: DynaMarker Protein MultiColor Stable, Low Range Code No: DM670L Lot No: ******* Size: 200 μl x 3 (DM670 x 3) (120 mini-gel lanes) Storage: 4 C Stability: 12 months at 4 C Storage Buffer:
More informationN-Glycosidase F Deglycosylation Kit
For life science research only. Not for use in diagnostic procedures. FOR IN VITRO USE ONLY. N-Glycosidase F Deglycosylation Kit Kit for the deglycosylation of asparagine-linked glycan chains on glycoproteins.
More informationPNGase F Instruction Manual
PNGase F Instruction Manual Catalog Number 170-6883 Bio-Rad Laboratories, 2000 Alfred Nobel Dr., Hercules, CA 94547 4006094 Rev A Table of Contents Section 1 Introduction...1 Section 2 Kit Components and
More informationSupplementary material: Materials and suppliers
Supplementary material: Materials and suppliers Electrophoresis consumables including tris-glycine, acrylamide, SDS buffer and Coomassie Brilliant Blue G-2 dye (CBB) were purchased from Ameresco (Solon,
More informationPurification and Characterization of a 43-Kilodalton Extracellular Serine Proteinase from Cryptococcus neoformans
JOURNAL OF CLINICAL MICROBIOLOGY, Feb. 2004, p. 722 726 Vol. 42, No. 2 0095-1137/04/$08.00 0 DOI: 10.1128/JCM.42.2.722 726.2004 Copyright 2004, American Society for Microbiology. All Rights Reserved. Purification
More informationCryptococcus neoformans Antigens
INFECTION AND IMMUNITY, Feb. 1988, p. 424-431 0019-9567/88/020424-08$02.00/0 Copyright 1988, American Society for Microbiology Vol. 56, No. 2 Serological, Electrophoretic, and Biological Properties of
More informationReceived 15 September 1997/Returned for modification 5 December 1997/Accepted 18 December 1997
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, Mar. 1998, p. 125 129 Vol. 5, No. 2 1071-412X/98/$04.00 0 Copyright 1998, American Society for Microbiology The Different Binding Patterns of Two Immunoglobulin
More informationThe Immunoassay Guide to Successful Mass Spectrometry. Orr Sharpe Robinson Lab SUMS User Meeting October 29, 2013
The Immunoassay Guide to Successful Mass Spectrometry Orr Sharpe Robinson Lab SUMS User Meeting October 29, 2013 What is it? Hey! Look at that! Something is reacting in here! I just wish I knew what it
More informationCryptococcal Antigen Latex Agglutination Test
Cryptococcal Antigen Latex Agglutination Test Cat. No.:DLAT1109 Pkg.Size:100T Intended use The Cryptococcal Antigen Latex Agglutination Test is a simple and rapid latex agglutination test for the qualitative
More informationTrypsin Mass Spectrometry Grade
058PR-03 G-Biosciences 1-800-628-7730 1-314-991-6034 technical@gbiosciences.com A Geno Technology, Inc. (USA) brand name Trypsin Mass Spectrometry Grade A Chemically Modified, TPCK treated, Affinity Purified
More informationSupplemental Figure 1 ELISA scheme to measure plasma total, mature and furin-cleaved
1 Supplemental Figure Legends Supplemental Figure 1 ELISA scheme to measure plasma total, mature and furin-cleaved PCSK9 concentrations. 4 Plasma mature and furin-cleaved PCSK9s were measured by a sandwich
More informationAntigenic Change of Native and Heat-Denatured Ovalbumin Digested with Pepsin, Trypsin or Chymotrypsin
J. Home Econ. Jpn. Vol. 48 No. 8 717 ` 722 (1997) Note Antigenic Change of Native and Heat-Denatured Ovalbumin Digested with Pepsin, Trypsin or Chymotrypsin Sumiko ODANI, Hiroko AWATUHARA* and Yukie KATO**
More informationCONTENTS. STUDY DESIGN METHODS ELISA protocol for quantitation of mite (Dermatophagoides spp.) Der p 1 or Der f 1
CONTENTS STUDY DESIGN METHODS ELISA protocol for quantitation of mite (Dermatophagoides spp.) Der p 1 or Der f 1 ELISA protocol for mite (Dermatophagoides spp.) Group 2 ALLERGENS RESULTS (SUMMARY) TABLE
More informationProtocol for Gene Transfection & Western Blotting
The schedule and the manual of basic techniques for cell culture Advanced Protocol for Gene Transfection & Western Blotting Schedule Day 1 26/07/2008 Transfection Day 3 28/07/2008 Cell lysis Immunoprecipitation
More informationHiPer Western Blotting Teaching Kit
HiPer Western Blotting Teaching Kit Product Code: HTI009 Number of experiments that can be performed: 5/20 Duration of Experiment: ~ 2 days Day 1: 6-8 hours (SDS- PAGE and Electroblotting) Day 2: 3 hours
More informationTECHNICAL BULLETIN. R 2 GlcNAcβ1 4GlcNAcβ1 Asn
GlycoProfile II Enzymatic In-Solution N-Deglycosylation Kit Product Code PP0201 Storage Temperature 2 8 C TECHNICAL BULLETIN Product Description Glycosylation is one of the most common posttranslational
More informationA mechanism for glycoconjugate vaccine activation of the adaptive immune system and its implications for vaccine design
A mechanism for glycoconjugate vaccine activation of the adaptive immune system and its implications for vaccine design Fikri Y. Avci 1,2, Xiangming Li 3, Moriya Tsuji 3, Dennis L. Kasper 1,2* Supplementary
More informationWilliams Lab Recipes ANTIBIOTICS
Williams Lab Recipes ANTIBIOTICS 1000x Ampicillin (sodium salt) 100mg/ml recipe 1. Measure out 1 g of Ampicillin tri hydrate 2. Add Milli-Q H2O to 10 ml 3. Add ~.1 g of NaOH pellets (half pellet or more
More informationEuropium Labeling Kit
Europium Labeling Kit Catalog Number KA2096 100ug *1 Version: 03 Intended for research use only www.abnova.com Table of Contents Introduction... 3 Intended Use... 3 Background... 3 Principle of the Assay...
More informationTSH Receptor Monoclonal Antibody (49) Catalog Number MA3-218 Product data sheet
Website: thermofisher.com Customer Service (US): 1 800 955 6288 ext. 1 Technical Support (US): 1 800 955 6288 ext. 441 TSH Receptor Monoclonal Antibody (49) Catalog Number MA3-218 Product data sheet Details
More informationCHAPTER 4 IMMUNOLOGICAL TECHNIQUES
CHAPTER 4 IMMUNOLOGICAL TECHNIQUES Nitroblue Tetrazolium Chloride (NBT) Reduction test NBT reduction test was evaluated by employing the method described by Hudson and Hay,1989 based upon principle that
More informationCharacterization of an Anticryptococcal Protein Isolated from Human Serum
INFECTION AND IMMUNITY, June 2000, p. 3787 3791 Vol. 68, No. 6 0019-9567/00/$04.00 0 Copyright 2000, American Society for Microbiology. All Rights Reserved. Characterization of an Anticryptococcal Protein
More informationMouse Cathepsin B ELISA Kit
GenWay Biotech, Inc. 6777 Nancy Ridge Drive San Diego, CA 92121 Phone: 858.458.0866 Fax: 858.458.0833 Email: techline@genwaybio.com http://www.genwaybio.com Mouse Cathepsin B ELISA Kit Catalog No. GWB-ZZD154
More informationBroad Spectrum Protease Inhibitor Cocktail
Broad Spectrum Protease Inhibitor Cocktail Catalog number: AR1182 Boster s Broad Spectrum Protease Inhibitor Cocktail is a complex of various protease inhibitors, which has been tested for inhibiting proteases
More informationCollagenase Assay Kit
Collagenase Assay Kit Catalog # 31 and 32 For Research Use Only - Not Human or Therapeutic Use INTRODUCTION The collagenases are members of the matrix metalloproteinase (MMP) family and degrade collagen
More informationSupplementary Information
Supplementary Information Supplementary Figure 1. CD4 + T cell activation and lack of apoptosis after crosslinking with anti-cd3 + anti-cd28 + anti-cd160. (a) Flow cytometry of anti-cd160 (5D.10A11) binding
More informationChapter PURIFICATION OF ALKALINE PROTEASES
Chapter PURIFICATION OF ALKALINE PROTEASES E /xtracellular alkaline proteases produced by Bacillus sp. K 25 and bacillus pumilus K 242, were purified and the homogeneity was examined by electrophoresis.
More informationRAPID SAMPLE PREPARATION METHODS FOR THE ANALYSIS OF N-LINKED GLYCANS
RAPID SAMPLE PREPARATION METHODS FOR THE ANALYSIS OF N-LINKED GLYCANS Zoltan Szabo, András Guttman, Tomas Rejtar and Barry L. Karger Barnett Institute, Boston, MA, USA PCT Workshop,Boston, 21 May, 2010.
More informationChromatin IP (Isw2) Fix soln: 11% formaldehyde, 0.1 M NaCl, 1 mm EDTA, 50 mm Hepes-KOH ph 7.6. Freshly prepared. Do not store in glass bottles.
Chromatin IP (Isw2) 7/01 Toshi last update: 06/15 Reagents Fix soln: 11% formaldehyde, 0.1 M NaCl, 1 mm EDTA, 50 mm Hepes-KOH ph 7.6. Freshly prepared. Do not store in glass bottles. 2.5 M glycine. TBS:
More informationScholars Research Library. Purification and characterization of neutral protease enzyme from Bacillus Subtilis
Journal of Microbiology and Biotechnology Research Scholars Research Library J. Microbiol. Biotech. Res., 2012, 2 (4):612-618 (http://scholarsresearchlibrary.com/archive.html) Purification and characterization
More informationDELFIA Eu-DTPA ITC Chelate & Europium Standard
AD0026P-3 (en) 1 DELFIA Eu-DTPA ITC Chelate & AD0021 Europium Standard For Research Use Only INTRODUCTION DELFIA Eu-DTPA ITC Chelate is optimized for the europium labelling of proteins and peptides for
More informationCaution: For Laboratory Use. A product for research purposes only. Eu-W1024 ITC Chelate & Europium Standard. Product Number: AD0013
TECHNICAL DATA SHEET Lance Caution: For Laboratory Use. A product for research purposes only. Eu-W1024 ITC Chelate & Europium Standard Product Number: AD0013 INTRODUCTION: Fluorescent isothiocyanato-activated
More informationEpidemiology and Laboratory Diagnosis of Fungal Diseases
Medical Mycology (BIOL 4849) Summer 2007 Dr. Cooper Epidemiology of Mycoses Epidemiology and Laboratory Diagnosis of Fungal Diseases Mycosis (pl., mycoses) - an infection caused by a fungus Two broad categories
More informationDELFIA Tb-N1 DTA Chelate & Terbium Standard
AD0029P-1 (en) 1 DELFIA Tb-N1 DTA Chelate & AD0012 Terbium Standard For Research Use Only INTRODUCTION DELFIA Tb-N1 DTA Chelate is optimized for the terbium labeling of proteins and peptides for use in
More informationINTERNATIONAL JOURNAL OF ENGINEERING SCIENCES & RESEARCH TECHNOLOGY
[Ravish, 2(2): Feb., 2013] ISSN: 2277-9655 IJESRT INTERNATIONAL JOURNAL OF ENGINEERING SCIENCES & RESEARCH TECHNOLOGY Isolation And Characterization Of Proteolytic Bacteria And Its Protease Himani Ravish
More informationantigen Y. Kajita, D. Morgan, A.B. Parkes and B. Rees Smith
Volume 87, number 2 FEBS 2756 August 985 Labelling and immunoprecipitation antigen of thyroid microsomal Y. Kajita, D. Morgan, A.B. Parkes and B. Rees Smith Endocrine Immunology Unit, 7th Floor Medicine.
More informationProtocol for protein SDS PAGE and Transfer
Protocol for protein SDS PAGE and Transfer According to Laemmli, (1970) Alaa El -Din Hamid Sayed, Alaa_h254@yahoo.com Serum Selection of a protein source cell cultures (bacteria, yeast, mammalian, etc.)
More informationSYNOPSIS STUDIES ON THE PREPARATION AND CHARACTERISATION OF PROTEIN HYDROLYSATES FROM GROUNDNUT AND SOYBEAN ISOLATES
1 SYNOPSIS STUDIES ON THE PREPARATION AND CHARACTERISATION OF PROTEIN HYDROLYSATES FROM GROUNDNUT AND SOYBEAN ISOLATES Proteins are important in food processing and food product development, as they are
More informationLANCE Eu-W1024 ITC Chelate & Europium Standard AD0013 Development grade
AD0017P-4 (en) 1 LANCE Eu-W1024 ITC Chelate & Europium Standard AD0013 Development grade INTRODUCTION Fluorescent isothiocyanato-activated (ITC-activated) Eu-W1024 chelate is optimized for labelling proteins
More informationValue o f Immunodiffusion Tests in the Diagnosis o f Systemic M ycotic Diseases
A n n a l s of C l i n i c a l L a b o r a t o r y S c i e n c e, Vol. 3, N o. 2 Copyright 1 9 7 3, Institute for Clinical Science Value o f Immunodiffusion Tests in the Diagnosis o f Systemic M ycotic
More informationLab Recipes. Destain 50% MeOH 40% milli-q water 10% Acetic Acid For 5 L total 2.5 liters Methanol 2 liters milli-q 0.5 liters Acetic Acid
1% Blotto 1 liter TTBS (aka TBST) 50 g nonfat dry milk 10 g BSA (Albumin, Bovine) Spike with 2 of 5% Sodium Azide (in hood) Shake it up and put it in the fridge Coomassie Stain 50% MeOH 10% Acetic Acid
More informationCollagenase Assay Kit
Collagenase Assay Kit Catalog # 31 and 32 For Research Use Only - Not Human or Therapeutic Use INTRODUCTION Collagenases are members of the matrix metalloproteinase (MMP) family and degrade collagen types
More informationSecondary fluorescent staining of virus antigens by rheumatoid factor and fluorescein-conjugated anti-lgm
Ann. rheum. Dis. (1973), 32, 53 Secondary fluorescent staining of virus antigens by rheumatoid factor and fluorescein-conjugated anti-lgm P. V. SHIRODARIA, K. B. FRASER, AND F. STANFORD From the Department
More informationInfluenza A H1N1 HA ELISA Pair Set
Influenza A H1N1 HA ELISA Pair Set for H1N1 ( A/Puerto Rico/8/1934 ) HA Catalog Number : SEK11684 To achieve the best assay results, this manual must be read carefully before using this product and the
More informationACTG Laboratory Technologist Committee Revised Version 2.0 ACTG Lab Man Coulter HIV-1 p24 ELISA May 21, 2004
Coulter HIV p24 1. PRINCIPLE The Human Immunodeficiency Virus Type 1 (HIV-1) is recognized as the etiologic agent of acquired immunodeficiency syndrome (AIDS). The virus is transmitted by sexual contact,
More informationSCS MOLECULAR WEIGHT MARKERS 2,500-17,000 Caltons
LECTROPHORES/S Revised November 1992 SCS MOLECULAR WEIGHT MARKERS 2,500-17,000 Caltons I NTRODUCTION Electrophoresis in polyacrylamide gels in the presence of sodium dodecyl sulfate (SDS), an anionic detergent,
More informationan antirubella antibody labelled with iodine-125 not require purified rubella antigen and, in general, are resistant to false positive results due to
J Clin Pathol 1985;38:1150-1154 Public Health Laboratory Service IgM antibody capture enzyme linked immunosorbent assay for detecting rubella specific IgM KATHRYN BELLAMY,* J HODGSON,t PS GARDNER,* P MORGAN-CAPNERt
More informationDELFIA Tb-DTPA ITC Chelate & Terbium Standard
AD0035P-2 (en) 1 DELFIA Tb-DTPA ITC Chelate & AD0029 Terbium Standard For Research Use Only INTRODUCTION DELFIA Tb-DTPA ITC Chelate is optimized for the terbium labelling of proteins and peptides for use
More informationI. Nonencapsulated Mutants
JOURNAL OF BACTERIOLOGY, Nov. 1967, p. 1475-1479 Vol. 94, No. 5 Copyright 1967 American Society for Microbiology Printed in U.S.A. Cryptococcus neoformans I. Nonencapsulated Mutants G. S. BULMER, M. D.
More informationThe Schedule and the Manual of Basic Techniques for Cell Culture
The Schedule and the Manual of Basic Techniques for Cell Culture 1 Materials Calcium Phosphate Transfection Kit: Invitrogen Cat.No.K2780-01 Falcon tube (Cat No.35-2054:12 x 75 mm, 5 ml tube) Cell: 293
More informationPRO G max Probiotic fermented soybean meal Benefits of PRO G max
PRO G max Probiotic fermented soybean meal Benefits of PRO G max Probiotic bacteria > 10 10 CFU/kg High protein with low molecular weight protein approaching small peptides enhancing digestion and absorption
More informationMammalian Tissue Protein Extraction Reagent
Mammalian Tissue Protein Extraction Reagent Catalog number: AR0101 Boster s Mammalian Tissue Protein Extraction Reagent is a ready-to-use Western blot related reagent solution used for efficient extraction
More informationRayBio KinaseSTAR TM Akt Activity Assay Kit
Activity Assay Kit User Manual Version 1.0 March 13, 2015 RayBio KinaseSTAR TM Akt Activity Kit Protocol (Cat#: 68AT-Akt-S40) RayBiotech, Inc. We Provide You With Excellent Support And Service Tel:(Toll
More informationHuman Cathepsin D ELISA Kit
GenWay Biotech, Inc. 6777 Nancy Ridge Drive San Diego, CA 92121 Phone: 858.458.0866 Fax: 858.458.0833 Email: techline@genwaybio.com http://www.genwaybio.com Human Cathepsin D ELISA Kit Catalog No. GWB-J4JVV9
More informationProduction and Preliminary Characterization of Alkaline Protease from Aspergillus flavus and Aspergillus terreus
ISSN: 0973-4945; CODEN ECJHAO E- Chemistry http://www.e-journals.net 2010, 7(2), 479-482 Production and Preliminary Characterization of Alkaline Protease from Aspergillus flavus and Aspergillus terreus
More informationFEBS 1138 January Paul R. Buckland and Bernard Rees Smith
Volume 166, number 1 FEBS 1138 January 1984 A structural comparison receptors by of guinea pig thyroid and fat TSH photoaffinity labelling Paul R. Buckland and Bernard Rees Smith Endocrine Immunology Unit,
More informationSTUDIES OF THE HEMAGGLUTININ OF HAEMOPHILUS PERTUSSIS HIDEO FUKUMI, HISASHI SHIMAZAKI, SADAO KOBAYASHI AND TATSUJI UCHIDA
STUDIES OF THE HEMAGGLUTININ OF HAEMOPHILUS PERTUSSIS HIDEO FUKUMI, HISASHI SHIMAZAKI, SADAO KOBAYASHI AND TATSUJI UCHIDA The National Institute of Health, Tokyo, Japan (Received: August 3rd, 1953) INTRODUCTION
More informationTrypsin Digestion Mix
G-Biosciences 1-800-628-7730 1-314-991-6034 technical@gbiosciences.com A Geno Technology, Inc. (USA) brand name 239PR Trypsin Digestion Mix Provides optimal buffered conditions for in gel trypsin digestion
More informationTHE ESTIMATION OF TRYPSIN WITH HEMOGLOBIN
THE ESTIMATION OF TRYPSIN WITH HEMOGLOBIN BY M. L. ANSON Am) A. E. MIRSKY (From the Laboratories of The Rockefeller Institute for Medical Research, Princeton, N. J., and the Hospital of The Rockefeller
More informationCaution: For Laboratory Use. A product for research purposes only. Eu-W1284 Iodoacetamido Chelate & Europium Standard. Product Number: AD0014
TECHNICAL DATA SHEET Lance Caution: For Laboratory Use. A product for research purposes only. Eu-W1284 Iodoacetamido Chelate & Europium Standard Product Number: AD0014 INTRODUCTION: Iodoacetamido-activated
More information2009 H1N1 Influenza ( Swine Flu ) Hemagglutinin ELISA kit
2009 H1N1 Influenza ( Swine Flu ) Hemagglutinin ELISA kit Catalog Number : SEK001 To achieve the best assay results, this manual must be read carefully before using this product and the assay is run as
More informationSupporting Information
Supporting Information Dauvillée et al. 10.1073/pnas.0907424106 Fig. S1. Iodine screening of the C. cohnii mutant bank. Each single colony was grown on rich-medium agar plates then vaporized with iodine.
More informationJyotika Sharma, Feng Dong, Mustak Pirbhai, and Guangming Zhong*
INFECTION AND IMMUNITY, July 2005, p. 4414 4419 Vol. 73, No. 7 0019-9567/05/$08.00 0 doi:10.1128/iai.73.7.4414 4419.2005 Copyright 2005, American Society for Microbiology. All Rights Reserved. Inhibition
More informationCurrent Status of Nonculture Methods for Diagnosis of Invasive Fungal Infections
CLINICAL MICROBIOLOGY REVIEWS, July 2002, p. 465 484 Vol. 15, No. 3 0893-8512/02/$04.00 0 DOI: 10.1128/CMR.15.3.465 484.2002 Copyright 2002, American Society for Microbiology. All Rights Reserved. Current
More informationPneumocystis caninii Organisms Obtained from Rats, Ferrets,
INFECrION AND IMMUNITY, Apr. 1993, p. 1315-1319 0019-9567/93/041315-05$02.00/0 Copyright C) 1993, American Society for Microbiology Vol. 61, No. 4 Pneumocystis caninii Organisms Obtained from Rats, Ferrets,
More informationThe total protein test is a rough measure of all of the proteins in the plasma. Total protein measurements can reflect:
Proteins Part 2 Introduction The total protein test is a rough measure of all of the proteins in the plasma. Total protein measurements can reflect: nutritional status, kidney disease, liver disease, and
More informationSubstrate Specificity and Salt Inhibition of Five Proteinases Isolated from the Pyloric Caeca and Stomach of Sardine
Agric. Biol. Chem., 46 (6), 1565~1569, 1982 1565 Substrate Specificity and Salt Inhibition of Five Proteinases Isolated from the Pyloric Caeca and Stomach of Sardine Minoru Noda, Thanh Vo Van, Isao Kusakabe
More informationInfluenza B Hemagglutinin / HA ELISA Pair Set
Influenza B Hemagglutinin / HA ELISA Pair Set Catalog Number : SEK11053 To achieve the best assay results, this manual must be read carefully before using this product and the assay is run as summarized
More informationLaboratorios CONDA, S.A. Distributed by Separations
Culture Media as on Pharmacopoeia 7.3, Harmonized Method for Microbiological Examination of non sterile products -FORMULATIONS Buffered sodium chloride-peptone solution ph 7.0 Cat. Nº 1401 Potassium dihydrogen
More informationPROTAZYME AK TABLETS
www.megazyme.com ASSAY OF endo-protease using PROTAZYME AK TABLETS T-PRAK 05/16 Megazyme International Ireland 2016 SUBSTRATE: The substrate employed is Azurine-crosslinked casein (AZCL-casein). This substrate
More informationHIV-1 p24 ANTIGEN CAPTURE ASSAY
HIV-1 p24 ANTIGEN CAPTURE ASSAY Enzyme Immunoassay for the detection of Human Immunodeficiency Virus Type 1 (HIV-1) p24 in tissue culture media. Catalog # 5421 株式会社東京未来スタイル Tokyo Future Style, Inc 305-0047
More informationProtease Activity Assay Kit (Fluorometric Red)
ab112153 Protease Activity Assay Kit (Fluorometric Red) Instructions for Use For detecting Protease activity in biological samples or to screen protease inhibitors using our proprietary red fluorescence
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Nair S, Branagan AR, Liu J, Boddupalli CS, Mistry PK, Dhodapkar
More informationHuman HBcAb IgM ELISA kit
Human HBcAb IgM ELISA kit Catalog number: NR-R10163 (96 wells) The kit is designed to qualitatively detect HBcAb IgM in human serum or plasma. FOR RESEARCH USE ONLY. NOT FOR DIAGNOSTIC OR THERAPEUTIC PURPOSES
More informationSUPPLEMENTAL INFORMATION
SUPPLEMENTAL INFORMATION EXPERIMENTAL PROCEDURES Tryptic digestion protection experiments - PCSK9 with Ab-3D5 (1:1 molar ratio) in 50 mm Tris, ph 8.0, 150 mm NaCl was incubated overnight at 4 o C. The
More informationSUPPLEMENTARY INFORMATION
Complete but curtailed T-cell response to very-low-affinity antigen Dietmar Zehn, Sarah Y. Lee & Michael J. Bevan Supp. Fig. 1: TCR chain usage among endogenous K b /Ova reactive T cells. C57BL/6 mice
More informationNature Methods: doi: /nmeth Supplementary Figure 1
Supplementary Figure 1 Subtiligase-catalyzed ligations with ubiquitin thioesters and 10-mer biotinylated peptides. (a) General scheme for ligations between ubiquitin thioesters and 10-mer, biotinylated
More informationGentilucci, Amino Acids, Peptides, and Proteins. Peptides and proteins are polymers of amino acids linked together by amide bonds CH 3
Amino Acids Peptides and proteins are polymers of amino acids linked together by amide bonds Aliphatic Side-Chain Amino Acids - - H CH glycine alanine 3 proline valine CH CH 3 - leucine - isoleucine CH
More informationab Membrane Fractionation Kit Instructions for Use For the rapid and simple separation of membrane, cytosolic and nuclear cellular fractions.
ab139409 Membrane Fractionation Kit Instructions for Use For the rapid and simple separation of membrane, cytosolic and nuclear cellular fractions. This product is for research use only and is not intended
More informationInfluenza or flu is a
Clinical and Research Area Infectious Diseases Influenza Virus Types A and B Influenza or flu is a respiratory illness that is caused by influenza viruses. Influenza viruses type A and type B cause seasonal
More informationInfluenza A H1N1 (Swine Flu 2009) Hemagglutinin / HA ELISA Pair Set
Influenza A H1N1 (Swine Flu 2009) Hemagglutinin / HA ELISA Pair Set Catalog Number : SEK001 To achieve the best assay results, this manual must be read carefully before using this product and the assay
More informationInstructions for Use. APO-AB Annexin V-Biotin Apoptosis Detection Kit 100 tests
3URGXFW,QIRUPDWLRQ Sigma TACS Annexin V Apoptosis Detection Kits Instructions for Use APO-AB Annexin V-Biotin Apoptosis Detection Kit 100 tests For Research Use Only. Not for use in diagnostic procedures.
More informationSTUDIES OF CRYPTOCOCCUS POLYSACCHARIDES BY INFRARED SPECTROPHOTOMETRY
STUDIES OF CRYPTOCOCCUS POLYSACCHARIDES BY INFRARED SPECTROPHOTOMETRY SEYMOUR LEVINE, E. EDWARD EVANS, AND PAUL W. KABLER From the St. Francis Hospital, Jersey City, New Jersey; the University of Alabama
More informationNational Standard of the People s Republic of China. National food safety standard. Determination of pantothenic acid in foods for infants and
National Standard of the People s Republic of China GB 5413.17 2010 National food safety standard Determination of pantothenic acid in foods for infants and young children, milk and milk products Issued
More informationInfluenza A H7N9 (A/Anhui/1/2013) Hemagglutinin / HA ELISA Pair Set
Influenza A H7N9 (A/Anhui/1/2013) Hemagglutinin / HA ELISA Pair Set Catalog Number : SEK40103 To achieve the best assay results, this manual must be read carefully before using this product and the assay
More informationSerrata) Alkaline Phosphatase
Vol. 41, No. 5, April 1997 BIOCHEMISTRY and MOLECULAR BIOLOGY INTERNATIONAL Pages 951-959 An Essential Tryptophan Residue of Green Crab (Syclla Serrata) Alkaline Phosphatase Wen-Zhu Zheng 1, Qing-Xi Chen
More informationTECHNICAL BULLETIN. Sialic Acid Quantitation Kit. Catalog Number SIALICQ Storage Temperature 2 8 C
Sialic Acid Quantitation Kit Catalog Number SIALICQ Storage Temperature 2 8 C TECHNICAL BULLETIN Product Description The Sialic Acid Quantitation Kit provides a rapid and accurate determination of total
More informationWork-flow: protein sample preparation Precipitation methods Removal of interfering substances Specific examples:
Dr. Sanjeeva Srivastava IIT Bombay Work-flow: protein sample preparation Precipitation methods Removal of interfering substances Specific examples: Sample preparation for serum proteome analysis Sample
More informationSTUDIES ON MUSTARD-STIMULATED PROTEASES AND INHIBITORS IN HUMAN EPIDERMAL KERATINOCYTES (HEK): DEVELOPMENT OF ANTIVESICANT DRUGS
STUDIES ON MUSTARD-STIMULATED PROTEASES AND INHIBITORS IN HUMAN EPIDERMAL KERATINOCYTES (HEK): DEVELOPMENT OF ANTIVESICANT DRUGS Xiannu Jin 1, Radharaman Ray 2, Guang Xu 1 and Prabhati Ray 1 1 Department
More informationPepsin Microplate Assay Kit User Manual
Pepsin Microplate Assay Kit User Manual Catalog # CAK1081 Detection and Quantification of Pepsin Activity in Urine, Serum, Plasma, Tissue extracts, Cell lysate, Cell culture media and Other biological
More informationBIL 256 Cell and Molecular Biology Lab Spring, Tissue-Specific Isoenzymes
BIL 256 Cell and Molecular Biology Lab Spring, 2007 Background Information Tissue-Specific Isoenzymes A. BIOCHEMISTRY The basic pattern of glucose oxidation is outlined in Figure 3-1. Glucose is split
More informationComparative Evaluation of Five Serological Methods for the Diagnosis of Sporotrichosis
APPLIED MICROBIOLOGY, JUly 1973, p. 4-8 Copyright 0 1973 American Society for Microbiology Vol. 26, No. 1 Printed in U.S.A. Comparative Evaluation of Five Serological Methods for the Diagnosis of Sporotrichosis
More informationE. Histolytica IgG ELISA Kit
E. Histolytica IgG ELISA Kit Catalog Number KA3193 96 assays Version: 01 Intended for research use only www.abnova.com Table of Contents Introduction... 3 Intended Use... 3 Background... 3 Principle of
More informationProtease Activity Assay Kit (Red)
Protease Activity Assay Kit (Red) Catalog Number KA2524 500 assays Version: 11 Intended for research use only www.abnova.com Table of Contents Introduction... 3 Background... 3 General Information... 4
More informationMitochondrial Trifunctional Protein (TFP) Protein Quantity Microplate Assay Kit
PROTOCOL Mitochondrial Trifunctional Protein (TFP) Protein Quantity Microplate Assay Kit DESCRIPTION Mitochondrial Trifunctional Protein (TFP) Protein Quantity Microplate Assay Kit Sufficient materials
More informationProtease Assay. (Cat. # ) think proteins! think G-Biosciences
389PR 01 G-Biosciences 1-800-628-7730 1-314-991-6034 technical@gbiosciences.com A Geno Technology, Inc. (USA) brand name Protease Assay (Cat. # 786 028) think proteins! think G-Biosciences www.gbiosciences.com
More information